Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

Uložené v:
Podrobná bibliografia
Vydané v:The New England journal of medicine Ročník 387; číslo 14; s. 1333 - 1336
Hlavní autori: Havervall, Sebastian, Marking, Ulrika, Svensson, Julia, Greilert-Norin, Nina, Bacchus, Philip, Nilsson, Peter, Hober, Sophia, Gordon, Max, Blom, Kim, Klingström, Jonas, Åberg, Mikael, Smed-Sörensen, Anna, Thålin, Charlotte
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Massachusetts Medical Society 06.10.2022
Predmet:
Antibodies
antibody detection
antibody response
controlled study
Coronavirus
coronavirus disease 2019
coronavirus spike glycoprotein
correlation coefficient
Correspondence
COVID-19
cycle threshold value
follow up
health care personnel
human
Humans
immunity
immunoglobulin A
immunoglobulin G
immunology
infection risk
Letter
major clinical study
Neutralizing
neutralizing antibody
nonhuman
polymerase chain reaction
prevention and control
risk reduction
SARS-CoV-2
SARS-CoV-2 Omicron
SARS-CoV-2 vaccine
screening
Spike Glycoprotein
spike protein
vaccinee
Viral
Viral Envelope Proteins
virology
virus antibody
virus envelope protein
virus replication
ISSN:0028-4793, 1533-4406, 1533-4406
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Bibliografia:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
Drs. Havervall, Marking, Klingström, Åberg, Smed-Sörensen, and Thålin contributed equally to this letter.
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMc2209651